1. Home
  2. CION vs SRZN Comparison

CION vs SRZN Comparison

Compare CION & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CION Investment Corporation

CION

CION Investment Corporation

N/A

Current Price

$6.75

Market Cap

324.2M

Sector

Finance

ML Signal

N/A

Logo Surrozen Inc.

SRZN

Surrozen Inc.

N/A

Current Price

$29.65

Market Cap

276.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CION
SRZN
Founded
2011
2015
Country
United States
United States
Employees
N/A
59
Industry
Finance/Investors Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.2M
276.3M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
CION
SRZN
Price
$6.75
$29.65
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$8.75
★ $47.50
AVG Volume (30 Days)
291.1K
★ 570.9K
Earning Date
11-05-2026
11-06-2026
Dividend Yield
★ 18.24%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $3,477,000.00
Revenue This Year
N/A
$208.89
Revenue Next Year
N/A
N/A
P/E Ratio
$17.55
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.83
$11.39
52 Week High
$10.40
$37.83

Technical Indicators

Market Signals
Indicator
CION
SRZN
Relative Strength Index (RSI) 50.95 58.65
Support Level $6.55 $23.31
Resistance Level $7.27 $28.78
Average True Range (ATR) 0.20 2.70
MACD 0.00 0.06
Stochastic Oscillator 76.67 73.14

Price Performance

Historical Comparison
CION
SRZN

About CION CION Investment Corporation

CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Companies portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Share on Social Networks: